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The  results of the  Polish nationwide cross­
­sectional study showed that depressive symp­
toms were found twice as often in patients with 
coronary artery disease than in participants free 
of this disease. Both men and women with de­
pressive symptoms are over twice as likely to 
have coronary artery disease, and 1.5­fold more 
INTRODUCTION A large body of evidence on 
associations between psychosocial risk factors 
and cardiovascular disease (CVD) has been col­
lected in the last 2 decades. Both clinical depres­
sion and depressive symptoms have been found 
to increase the risk of incidence of coronary ar­
tery disease1 as well as worsen its prognosis.2 
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ABSTRACT
BACKGROUND Depression was found to increase the risk of cardiovascular disease (CVD). In terms of CVD 
prevention in people with depressive symptoms, the main goal is to successfully control classic CVD risk 
factors.
AIMS The aim of the study was to assess the relationship between depression and 1) the frequency 
of healthcare utilization, 2) counseling on main CVD risk factors during usual medical visits, 3) compliance 
with pharmacotherapy in primary and secondary prevention.
METHODS WOBASZ II was a cross ‑sectional study targeting a representative sample of the Polish 
population. Trained nurses obtained information on depression (using the Beck Depression Inventory), 
education, healthcare utilization, counseling on CVD risk factors, and compliance with the recommended 
pharmacotherapy.
RESULTS As many as 5531 participants completed the Beck Depression Inventory questionnaire and 
provided information on CVD. After adjustment for age, sex, and education, participants without CVD 
but with depression had blood pressure measured slightly more often and received more frequent 
counseling on: nutrition (40% more), physical activity (43% more), and smoking cessation (nearly 30% 
more). Counseling on main CVD risk factors during typical visits and compliance with the recommended 
pharmacotherapy did not differ with regards to depression in patients with a history of CVD.
CONCLUSIONS The recommendations from the European Society of Cardiology for particularly careful 
control of CVD risk factors in people with depression are to some extent reflected in primary prevention. 
The relationship between depression and counseling on CVD risk factors in patients with CVD was 
insignificant. Compliance with the recommended pharmacotherapy was not related to depression.
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a  nationwide, cross ­sectional study aiming 
to achieve a sample representative for the to­
tal Polish population aged 20 years and older. 
The sample was drawn from the national popu­
lation register, using a multistage sampling de­
sign. The main goals, methods, and sample selec­
tion in the WOBASZ II study have been report­
ed previously.15 Brief summary of information 
relevant for this publication is given below. Out 
of a randomly selected 15 200 residents, 13 643 
were eligible for the study (10% of the sample 
were deceased, changed their place of residence, 
or contact was impossible due to poor health sta­
tus). The response rate was 45.5%.
Data collection Trained nurses interviewed 
participants following a standard questionnaire. 
Data were obtained on depressive symptoms, ed­
ucation, CVD risk factors, and healthcare utili­
zation characteristics. Blood collection for bio­
chemical tests was performed according to stan­
dardized methods.
Measurements Depression was assessed 
using the Beck Depression Inventory (BDI).16 
The BDI included 21 items scored 0 to 3. The to­
tal possible score was from 0 (lack of depres­
sion symptoms) to 63 (highest depression symp­
toms). A cutoff point of 10 or higher was ac­
cepted.17 The BDI was administered to partici­
pants aged 20 to 74 years (92% of the sample). 
Healthcare utilization was assessed by asking 
about hospitalization in the previous 12 months 
(yes / no) and medical consultations in the pre­
vious 12 months (yes / no). Counseling on CVD 
risk factors was assessed using the following 
questions: “During a typical medical visit, do 
you usually: 1) have your blood pressure mea­
sured? 2) receive advice regarding smoking ces­
sation? 3) receive nutritional advice? 4) receive 
advice to increase physical activity?” Compli­
ance with any recommended pharmacotherapy 
was assessed by asking the respondent wheth­
er they bought all the drugs prescribed dur­
ing their last medical visits (“Yes, bought and 
take medications according to the medical rec­
ommendation” vs “Did not buy or bought but 
do not use medications according to medical 
recommendations”).
Statistical analysis Distributions of partici­
pants’ ages are presented as means (SD) accord­
ing to subgroups by depression symptoms and 
history of CVD. Differences in mean age were 
assessed using the t test. Categorical variables 
are presented as raw numbers and percentages. 
Comparisons of the distributions of categorical 
variables with categories of depression symp­
toms were done using the χ2 test. The main sta­
tistical method was multivariable logistic re­
gression. The relationships between healthcare 
utilization, CVD risk factors counseling and 
likely to report myocardial infarction and ar­
rhythmia.3 The evidence from a prospective co­
hort study including Polish, Czech, and Rus­
sian data indicated that in Central and East­
ern Europe the strength of the association be­
tween depression and CVD mortality is similar 
to the effect observed in the case of classic risk 
factors.4 However, no method for the effective 
management of psychosocial risk factors has 
been described yet. Studies assessing the effect 
of treatment of clinically significant depression 
on improvement in CVD outcomes have been in­
conclusive.5,6 Currently, the main goal for peo­
ple with depressive symptoms is to pay special 
attention to successful control of classic CVD 
risk factors such as hypertension, hypercholes­
terolemia, and smoking. This is especially im­
portant as there is evidence that persons free of 
CVD with depressive symptoms have a poorer 
diet,7 smoke more often,8,9 and have low levels 
of physical activity.10 The latest findings from 
the Framingham Study confirmed that depres­
sive symptoms might act as a barrier for medi­
cation adherence, which exacerbates CVD risk 
factors in older adults.11
Also, in secondary prevention, patients with 
depression are more exposed to the main CVD 
risk factors, less likely to be open to lifestyle 
change, and less compliant to cardioprotective 
medication.12-14 Although a clear need to con­
trol the major CVD risk factors is well justified, 
studies addressing the care of people with de­
pression related to CVD are scarce.
The objective of the present study was to 
assess the relationship between depression 
and: 1) the frequency of healthcare utilization, 
2) counseling on the main CVD risk factors dur­
ing usual medical visits, and 3) compliance with 
the pharmacotherapy recommended in prima­
ry and secondary prevention.
METHODS Study population The  Multi­
­Center National Population Health Examina­
tion Survey (WOBASZ II study) was conduct­
ed in Poland between 2013 and 2014. This was 
WHAT’S NEW?
The Study assessed whether the recommendations of the European Society 
of Cardiology for the particularly careful control of the main risk factors 
in people with unfavorable psychosocial characteristics are reflected in everyday 
medical practice. The WOBASZ II study targeted a representative sample 
of the Polish population and found that, in primary prevention, people with 
depression more often receive counseling on the main cardiovascular disease 
risk factors during typical visits than those without depression. The association 
between depression and counseling on cardiovascular disease risk factors 
in secondary prevention was insignificant; however, this issue seems to require 
more thorough research in terms of the scope and quality of medical visits for 
patients with cardiovascular disease. Compliance with the recommended 
pharmacotherapy was not related to depression.
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more likely to attend medical consultations or 
to be hospitalized (45% and 71% more, respec­
tively) (TABLE 2). Compared with participants with­
out depression, the former also slightly more of­
ten had their blood pressure measured, and re­
ceived more frequent counseling on: nutrition 
(40% more), physical activity (43% more), and 
smoking cessation (nearly 30% more). No as­
sociation between compliance with pharmaco­
therapy linked to depression was found in par­
ticipants free of CVD.
The frequency of medical visits, hospitaliza­
tions, counseling on the main CVD risk fac­
tors during typical visits, and compliance with 
the recommended pharmacotherapy did not 
differ between patients with a history of CVD 
with depression as compared with those with­
out depression.
DISCUSSION Our results suggest that, in pri­
mary prevention, persons with depression use 
medical care more often and receive counsel­
ing on the main CVD risk factors during typi­
cal visits more frequently. However, in persons 
with CVD, the prevalence of depression was not 
related either to frequency of medical care use 
or to frequency of counseling on CVD risk fac­
tors. Our findings did not confirm noncompli­
ance with recommended pharmacotherapy in 
participants with depression.
The results for participants free of CVD in­
dicate that recommended intensified control 
of the main risk factors in people with unfa­
vorable psychosocial characteristics is imple­
mented. Comprehensive advice in terms of ma­
jor risk factors, if effective, has the potential 
to reduce CVD risk associated with depressive 
symptoms. To the best of our knowledge, no 
Polish studies have been published assessing 
compliance with pharmacotherapy and histo­
ry of CVD were assessed using logistic regres­
sion after adjusting for age. The associations be­
tween the above variables and depression symp­
toms were assessed after adjusting for age, sex, 
and education. Analysis was run for the strata 
of the history of CVD. The results are presented 
as odds ratios (ORs) with 95% CI. All analyses 
were done using the statistical package STATA 
version 14 (StataCorp LP, College Station, Tex­
as, United States).
RESULTS As many as 5531 participants com­
pleted the BDI questionnaire and provided in­
formation on CVD. Of these participants, 567 
had a positive history of CVD. In persons with 
CVD, medical visits, hospitalizations, and coun­
seling were more frequent than in participants 
free of CVD (FIGURE 1). TABLE 1 presents descriptive 
statistics for age, sex, education, healthcare uti­
lization characteristics, frequency of counseling 
on CVD risk factors, and compliance with phar­
macotherapy recommended by depression and 
history of CVD. Among participants free of CVD, 
persons with depression were on average 5 years 
older, predominantly women, and had lower ed­
ucation. Both hospitalizations and medical con­
sultations in the previous 12 months were more 
prevalent in participants with depression. The 
number of blood pressure measurements and 
counseling on nutrition, physical activity, and 
smoking cessation during typical visits was also 
higher in persons with depression. Similar to 
participants free of CVD, in participants with 
CVD, depression was more prevalent in wom­
en. No other differences in terms of depression 
were found in participants with CVD.
After adjustment for age, sex, and education, 
participants free of CVD with depression were 
 FIGURE 1 Prevalence of healthcare utilization characteristics, frequencies of counseling on cardiovascular disease (CVD) risk factors, and compliance with 
pharmacotherapy recommended in participants with CVD, adjusted for age (reference: participants free of CVD)
 Abbreviations: OR, odds ratio
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patients recalled advice on risk factors dur­
ing typical visits, irrespective of depressive 
symptoms. The results of EUROASPIRE (Eu­
ropean Action on Secondary and Primary 
Prevention through Intervention to Reduce 
Events) studies showed that achievement 
of treatment targets in terms of classic risk 
factors in secondary prevention in Poland 
is substantially higher than in the general 
population.2 2 This may suggest that patients 
with CVD receive more intensive care and 
that is why the differences between patients 
with and without depression are attenuated. 
the control of CVD risk factors in terms of de­
pressive symptoms. However, in the general pop­
ulation, the control of the main CVD risk fac­
tors is rather poor,18-21 so although participants 
with depressive symptoms receive more frequent 
counseling, there is still room for improvement.
Our results in participants with CVD in­
dicated no significant difference in the fre­
quency of CVD risk factors counseling relat­
ed to depressive symptoms. However, CVD 
patients in general have more medical visits 
and are more intensively advised in terms 
of CVD risk factors, so the majority of these 
TABLE 1 Distribution of age, sex, education, healthcare utilization, frequency of counseling on cardiovascular disease risk factors and 
compliance with recommended pharmacotherapy by depression and history of cardiovascular disease
Parameter Free of CVD (N = 4964) History of CVD (N = 567)
Low BDIa 
(n = 3993)
High BDIb 
(n = 971)
P value Low BDIa 
(n = 330)
High BDIb 
(n = 237)
P value
Age, mean (SD) 44.4 (13.9) 49.3 (14.3) <0.001 60.0 (9.6) 61.7 (9.9) 0.06
Male sex 1.869 (46.8) 351 (36.2) <0.001 180 (54.6) 109 (46.0) 0.04
Education Primary / vocational 1323 (33.2) 433 (44.8) <0.001 177 (53.6) 141 (59.5) 0.36
High 1.565 (39.2) 338 (35.0) 118 (35.8) 76 (32.1)
University 1101 (27.6) 196 (20.3) 35 (10.6) 20 (8.4)
Married / cohabiting 2762 (69.2) 618 (63.7) 242 (73.3) 162 (68.4)
≥1 hospitalization in the previous 12 months 351 (8.8) 146 (15.04) <0.001 92 (28.0) 79 (33.3) 0.17
≥1 medical visit in the previous 12 months 2883 (72.3) 790 (81.4) <0.001 319 (97.0) 228 (96.2) 0.62
Blood pressure measurement 1927 (52.6) 562 (61.5) <0.001 283 (86.5) 203 (87.1) 0.84
Nutritional advice 857 (23.6) 299 (33.1) <0.001 174 (55.2) 116 (52.0) 0.46
Physical activity advice 700 (19.3) 243 (26.9) <0.001 143 (45.4) 92 (40.9) 0.3
Anti tobacco advice 512 (49.2) 179 (57.2) 0.01 61 (84.7) 58 (80.6) 0.51
Compliance Yes 2729 (92.2) 721 (91.2) 0.32 291 (93.6) 216 (93.5) 0.98
No 230 (7.8) 70 (8.9) 20 (6.4) 15 (6.5)
Data are presented as number (percentage) unless otherwise indicated.
a BDI <10
b BDI ⩾10
Abbreviations: BDI, Beck Depression Inventory; CVD, cardiovascular disease
TABLE 2 Association between depressive symptoms and the frequency of healthcare utilization, compliance with pharmacotherapy 
recommended, and counseling on main cardiovascular disease risk factors during usual medical visits (reference category: Beck Depression 
Inventory <10)
Parameter Medical 
consultation 
in the last 
12 months
Hospitalization 
in the last 
12 months
Noncompliance with 
recommended 
pharmacotherapy
Blood pressure 
measurement
Nutritional 
counseling
Physical 
activity 
counseling
Antitobacco 
counseling
Free of CVD 
(n = 4964)
1.45 (1.21–1.74) 1.71 (1.39–2.12) 1.24 (0.93–1.65) 1.15 (0.98–1.36) 1.40 (1.19–1.65) 1.43 (1.20–1.70) 1.29 (0.99–1.69)
History of CVD 
(n = 567)
0.65 (0.25–1.66) 1.32 (0.91–1.90) 1.00 (0.50–2.02) 0.99 (0.59–1.68) 0.86 (0.61–1.22) 0.85 (0.60–1.21) 0.75 (0.30–1.86)
Data are presented as odds ratio (95% CI). Adjusted for age, sex, and education.
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depression and counseling on the main CVD 
risk factors in patients with CVD was insig­
nificant; however, more thorough research on 
the scope and quality of medical visits in pa­
tients with CVD is needed. Compliance with 
pharmacotherapy recommended by healthcare 
professionals was not related to depression.
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